November 24th, 2014
This week’s topics include the PROTECT-AF trial, the association of inpatient vs. outpatient onset of STEMI with treatment and clinical outcomes, and more.
September 10th, 2014
The controversial polypill took one step closer to reaching the U.S. market after receiving a mostly positive reception from the FDA’s Cardiovascular and Renal Drugs Advisory Committee on Wednesday. The idea for the polypill– which in this case would be composed of aspirin, a statin, and one or more blood pressure drugs– has been kicking around for […]
October 29th, 2013
Khurram Nasir discusses his research group’s JACC study, which examines whether the coronary artery calcium score can be used to determine the target population for a polypill.